The Oncology Institute, Inc. (TOIIW) NASDAQ

0.11

-0.0199(-15.31%)

Updated at October 16 04:00PM

Currency In USD

Valuation

Market Cap23.19M
Enterprise Value96.67M
P/E Ratio-54.04
PEG Ratio-18.91
Price/Sales Ratio0.84
Price/Book Ratio-396.26
Enterprise/Revenue1.01
Enterprise/EBITDA-8.9

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.16
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.41
Return On Equity-17.39

Income Statement

Revenue393.41M
Revenue/Share0.46
Gross Profit54M
EBITDA-50.88M
Net Income-64.66M
Diluted EPS-0.71

Balance Sheet

Total Cash30.29M
Total Cash/Share0.03
Total Debt103.16M
Total Debt/Equity-11.48
Current Ratio1.62
Book Value Per Share-0.01

Price History

52-Week Change450.5
52-Week High0.13
52-Week Low0.11
Moving Average 50 Days0.12
Moving Average 200 Days0.06

Statistics

Average Volume23,458.45
Shares Outstanding2.64B
% Held by Institutions4.94M

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A